TY - JOUR
T1 - CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs
AU - CanScreen5 collaborators
AU - Zhang, Li
AU - Mosquera, Isabel
AU - Lucas, Eric
AU - Rol, Mary Luz
AU - Carvalho, Andre L.
AU - Basu, Partha
AU - Sadowski, Daniel
AU - Natasha, Bartlett
AU - Budd, Alison
AU - Nessa, Ashrafun
AU - De Brabander, Isabel
AU - Haelens, Annemie
AU - Pringels, Sarah
AU - Tairo, Jonas
AU - Hofvind, Solveig
AU - Burrion, J. B.
AU - Valerianova, Zdravka
AU - Tinmouth, Jill
AU - Law, Cindy
AU - Ebenuwah, Simbi
AU - McCurdy, Bronwen
AU - Janik, Beata
AU - Pupwe, George
AU - Groeneveld, Linn Fenna
AU - Skare, Gry Baadstrand
AU - Layne, Penelope
AU - Sarkeala, Tytti
AU - Chaila, Mwate Joseph
AU - Kaminski, Michal
AU - Kinel, Beata
AU - Lissowska, Jolanta
AU - Mumukunde, Inga
AU - Rodrigues, Vitor
AU - Rodríguez, Robinson
AU - Sanz, Elena Pérez
AU - Alberdi, Raquel Zubizarreta
AU - Ronco, Guglielmo
AU - Antoljak, Nataša
AU - Nakić, Dinka
AU - Plazanin, Davor
AU - Parun, Andrea Šupe
AU - Goossens, Mat
AU - Nowakowski, Andrzej
AU - de Koning, Harry
AU - Dams, Els
AU - Martin, Asha
AU - Epermane, Mara
AU - Jankovska, Nataļja
AU - Latinovic, Radoslav
AU - Mackie, Anne
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/5
Y1 - 2023/5
N2 - The CanScreen5 project is a global cancer screening data repository that aims to report the status and performance of breast, cervical and colorectal cancer screening programs using a harmonized set of criteria and indicators. Data collected mainly from the Ministry of Health in each country underwent quality validation and ultimately became publicly available through a Web-based portal. Until September 2022, 84 participating countries reported data for breast (n = 57), cervical (n = 75) or colorectal (n = 51) cancer screening programs in the repository. Substantial heterogeneity was observed regarding program organization and performance. Reported screening coverage ranged from 1.7% (Bangladesh) to 85.5% (England, United Kingdom) for breast cancer, from 2.1% (Côte d’Ivoire) to 86.3% (Sweden) for cervical cancer, and from 0.6% (Hungary) to 64.5% (the Netherlands) for colorectal cancer screening programs. Large variability was observed regarding compliance to further assessment of screening programs and detection rates reported for precancers and cancers. A concern is lack of data to estimate performance indicators across the screening continuum. This underscores the need for programs to incorporate quality assurance protocols supported by robust information systems. Program organization requires improvement in resource-limited settings, where screening is likely to be resource-stratified and tailored to country-specific situations.
AB - The CanScreen5 project is a global cancer screening data repository that aims to report the status and performance of breast, cervical and colorectal cancer screening programs using a harmonized set of criteria and indicators. Data collected mainly from the Ministry of Health in each country underwent quality validation and ultimately became publicly available through a Web-based portal. Until September 2022, 84 participating countries reported data for breast (n = 57), cervical (n = 75) or colorectal (n = 51) cancer screening programs in the repository. Substantial heterogeneity was observed regarding program organization and performance. Reported screening coverage ranged from 1.7% (Bangladesh) to 85.5% (England, United Kingdom) for breast cancer, from 2.1% (Côte d’Ivoire) to 86.3% (Sweden) for cervical cancer, and from 0.6% (Hungary) to 64.5% (the Netherlands) for colorectal cancer screening programs. Large variability was observed regarding compliance to further assessment of screening programs and detection rates reported for precancers and cancers. A concern is lack of data to estimate performance indicators across the screening continuum. This underscores the need for programs to incorporate quality assurance protocols supported by robust information systems. Program organization requires improvement in resource-limited settings, where screening is likely to be resource-stratified and tailored to country-specific situations.
UR - https://www.scopus.com/pages/publications/85153764106
U2 - 10.1038/s41591-023-02315-6
DO - 10.1038/s41591-023-02315-6
M3 - Article
C2 - 37106168
AN - SCOPUS:85153764106
SN - 1078-8956
VL - 29
SP - 1135
EP - 1145
JO - Nature Medicine
JF - Nature Medicine
IS - 5
ER -